Videos

Adam Brufsky, MD, PhD, addresses the potential for changing dynamics in SARS-CoV-2.

A brief on the latest infectious disease headlines.

Matthew F. Pullen, MD, co-author of the recent hydroxychloroquine prophylaxis trial, shares the top clinical takeaways.

Why people may need to readjust their expectations around COVID-19 clinical data and drugs.

John Strotbeck, Olympian and CEO of Boathouse Sports, explains how and why the outerwear company pivoted to PPE production at the start of the COVID-19 pandemic.

A review of the latest infectious disease news.

Sarah Jorgensen, PharmD, MPH, BCPS, BCIDP, AAHIVP, provides a deep dive on the pharmacology and biochemistry of remdesivir.

A look at the means by which clinicians are quantifying and evaluating the effects of the antiviral drug.

It's been one month since the antiviral therapy was granted emergency use authorization. How has it affected COVID-19 care?

A daily infectious disease news update

Kelly Cawcutt, MD, MS, shares her thoughts on COVID's impact on health care, as well as why it's so important for clinicians to take breaks.

A brief on our top stories from May 28, 2020.

Debbie Goff, PharmD, describes how antimicrobial stewardship work has continued during the COVID-19 pandemic.

A daily news update on our COVID-19 coverage.

Helen W. Boucher, MD, FACP, FIDSA, discusses the need for a transparent distribution process for remdesivir, plus COVID disparities, secondary infections, and what “the new normal” of health care looks like.

Vickie Mays, PhD, uses her training in clinical psychology to provide insight on the long-term cognitive impact of the coronavirus pandemic and outbreak response.

Saskia v. Popescu, PhD, MPH, MA, CIC, discusses vaccine development, fighting COVID misinformation, and lessons learned from the pandemic.

An update on our daily coverage.

A daily news update on our COVID-19 coverage.

Monica V. Mahoney, PharmD, BCPS AQ-ID, BCIDP chats with assistant editor Grant M. Gallagher on the evolving nature of outpatient infectious disease care in light of the COVID-19 pandemic.

Adam Brufsky, MD, discusses the potential of multiple SARS-CoV-2 viral strains.

Today's trending stories in infectious disease news.

Miriam Isola, PhD, talks to us about the use of phone apps for COVID-19 contact tracing.

Armand Balboni, MD, PHD, CEO of Appili Therapeutics, discusses work with favipiravir on a new front for the drug — the global search for COVID-19 treatment and prevention therapies.

Patient stratification, demographic representations, and plasma collection could aid the pursuit for an efficacious prophylaxis.

A summary of Contagion's top stories for May 15, 2020.

Elizabeth Leung, PharmD, shares SIDP's educational efforts surrounding COVID-19 treatment.

A briefing on the day's top stories.

In the first part of a discussion with the medical oncologist from UPMC Hillman Cancer Center, Brufsky discusses the potential role of hyperglycemia in severity of COVID-19.

A summary of today's top stories.